Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 12, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized management to explore an initial public...
-
Mar 8, 2007
Boston Scientific Corporation (NYSE: BSX) today announced several enhancements related to the governance of the company. "Boston Scientific is...
-
Mar 6, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Cowen Health Care Conference, which is being held March 12 - 15 in...
-
Mar 5, 2007
Boston Scientific Corporation (NYSE: BSX) released the following statement today in response to a request for information relating to its TAXUS®...
-
Feb 28, 2007Campaign spokesperson - a Formula race car driver, amputee, and chronic pain patient - to promote public awareness
Boston Scientific Corporation (NYSE: BSX) announced today the launch of its Neuromodulation Group's Race Against Pain public outreach campaign to...
-
Feb 12, 2007
Boston Scientific Corporation (NYSE: BSX) today commented on results from a Swedish registry assessing the long-term outcomes of drug-eluting...
-
Feb 12, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed the online release of several important articles scheduled for publication in the March...
-
Feb 5, 2007DES patients have significantly lower rates of death, heart attack and re-intervention than BMS patients
Boston Scientific Corporation (NYSE: BSX) today welcomed data from a study showing that drug- eluting stents (DES) have substantially lower rates of...
-
Feb 2, 2007
Boston Scientific Corporation (NYSE: BSX) today commented on a proposed National Coverage Determination (NCD) released by the Centers for Medicare...
-
Feb 1, 2007Company provides guidance for first quarter 2007
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2006, as well as...
-
Jan 31, 2007
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...
-
Jan 29, 2007Longer balloon gives physicians broader treatment options in peripheral artery disease
Boston Scientific Corporation (NYSE: BSX) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to expand its...
-
Jan 25, 2007
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...
-
Jan 18, 2007New U.S. shelf life is longer than any competing drug-eluting stent product
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved extending the shelf life of...
-
Jan 17, 2007Court Orders Injunction and Damages
Boston Scientific Corporation (NYSE: BSX) announced today that it and Angiotech Pharmaceuticals, Inc. (Nasdaq: ANPI; TSX: ANP) won a patent...
-
Jan 16, 2007
Boston Scientific Corporation (NYSE: BSX) commented on a decision today by the U.K. Court of Appeal that affirmed an earlier ruling by a lower...
-
Jan 12, 2007Lower rates of re-intervention and major adverse events reported for the TAXUS Stent in study of diabetic patients
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of an independent study demonstrating that Boston Scientific's TAXUS®...
-
Jan 11, 2007Boston Scientific only company to offer two distinct drug-eluting stent platforms
Boston Scientific Corporation (NYSE:BSX) today announced the international launch and first implantation of the PROMUS(TM) Everolimus-Eluting...
-
Jan 10, 2007
Boston Scientific Corporation (NYSE: BSX) today announced preliminary, unaudited net sales for its fourth quarter and full year ended December 31,...
-
Jan 8, 2007Plan to increase innovation, productivity and competitiveness
Boston Scientific Corporation (NYSE: BSX) today announced a plan to reallocate its cardiac rhythm management (CRM) research and development...
-
Jan 4, 2007Acquisition demonstrates Company's commitment to leadership in treating carotid artery disease
Boston Scientific Corporation (NYSE: BSX) today announced it has acquired EndoTex Interventional Systems, Inc. The acquisition follows the Food and...
-
Jan 3, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the JP Morgan Health Care Conference, which is being held January 8 - 11 in...
-
Jan 2, 2007Trial highlights the importance of appropriate pacing for patients at risk of sudden cardiac death
Boston Scientific Corporation (NYSE: BSX) today announced that results of the largest implantable cardioverter defibrillator (ICD) study to date,...
-
Dec 15, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling certain lots of the Mach 1® Guide Catheter in the...
-
Dec 14, 2006Device now cleared for use in both carotid arteries and saphenous vein grafts
Boston Scientific Corporation (NYSE: BSX) today announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market its...